本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Kalvista Pharmaceuticals Inc

15.39
-0.6200-3.87%
盤後15.400.0100+0.06%17:57 EDT
成交量:127.91萬
成交額:2,012.97萬
市值:7.66億
市盈率:-4.17
高:16.23
開:15.90
低:15.30
收:16.01
資料載入中...
2022/10/17

重要事件披露

8-K - Current report
2022/09/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/08

重要事件披露

8-K - Current report
2022/08/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/07/07

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/07/07

重要事件披露

8-K - Current report
2022/05/27

重要事件披露

8-K - Current report
2022/05/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/18

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/10

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/10

重要事件披露

8-K - Current report
2022/03/07

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals